Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients. (PubMed, Clin Transplant) - May 28, 2025 - "In our experience, letermovir was well tolerated and effective in the management of resistant CMV in pediatric heart transplant recipients."
Journal • Cytomegalovirus Infection • Infectious Disease • Pediatrics • Transplantation
|
|
Debbie-Ann Shirley; Dipankar Gupta; Emily Martin; John-Anthony Coppola; Varvara Probst
|